Physician
North Shore Hematology Oncology Associates PC
North Shore Hematology Oncology Associates PC was paid $731K by Medicaid between Jan 2018 and Jul 2024, across 27 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 51% of everything it billed.
33Billing provider infoNORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
POUGHKEEPSIE, NY 12601
POUGHKEEPSIE, NY 12601
33aNPI1275615809assigned 10/20/2006
33bProvider typeDiagnostic Radiology Physician
28Total paid$731K
24GClaims27,588
24DCodes billed27
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Diagnostic Radiology Physician providers in New York
Rank by total paid#56 of 1,568
Median peer was paid$5K
This provider vs. median135×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 954 | $21K | |
| 2019 | 1,959 | $61K | |
| 2020 | 3,706 | $106K | |
| 2021 | 5,307 | $176K | |
| 2022 | 5,777 | $142K | |
| 2023 | 6,896 | $146K | |
| 2024incomplete | 2,989 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 51% | 2,920 | 2,702 | $374K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 1,105 | 1,071 | $101K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 13% | 1,150 | 685 | $93K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.6% | 10,475 | 8,255 | $48K |
| 80053 | Comprehensive metabolic panel | 2.8% | 2,687 | 2,385 | $20K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 1.8% | 348 | 205 | $13K |
| 99223 | Prolong inpt eval add15 m | 1.7% | 69 | 68 | $13K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.6% | 175 | 99 | $12K |
| 83615 | 1.4% | 2,455 | 2,193 | $10K | |
| 82728 | <1% | 614 | 595 | $6K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | <1% | 60 | 28 | $5K |
| 83735 | <1% | 1,074 | 930 | $5K |
15 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 318 | $5K |
| 84466 | <1% | 491 | $5K | |
| 82977 | <1% | 810 | $4K | |
| 84100 | <1% | 1,057 | $3K | |
| 82607 | <1% | 294 | $3K | |
| 82746 | <1% | 293 | $3K | |
| 84550 | <1% | 951 | $3K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 21 | $2K |
| 96367 | <1% | 23 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 43 | $461.16 |
| 84480 | <1% | 48 | $417.98 | |
| 84439 | <1% | 48 | $276.57 | |
| 83550 | <1% | 16 | $95.34 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 27 | $77.56 |
| 83540 | <1% | 16 | $70.48 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDANDRAIA, PATRICIA (SENIOR DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| North Shore Hematology Oncology Associates PC | Port Jefferson Station, NY | $61.66M |
| North Shore Hematology Oncology Associates PC | New Hyde Park, NY | $153K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.